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Abstract
Background: Colorectal cancer is one of the most common causes of cancer-related mortality.
The disease is clinically and genetically heterogeneous though a strong hereditary component has
been identified. However, only a small proportion of the inherited susceptibility can be ascribed to
dominant syndromes, such as Hereditary Non-Polyposis Colorectal Cancer (HNPCC) or Familial
Adenomatous Polyposis (FAP). In an attempt to identify novel colorectal cancer predisposing
genes, we have performed a genome-wide linkage analysis in 30 Swedish non-FAP/non-HNPCC
families with a strong family history of colorectal cancer.
Methods:  Statistical analysis was performed using multipoint parametric and nonparametric
linkage.
Results: Parametric analysis under the assumption of locus homogeneity excluded any common
susceptibility regions harbouring a predisposing gene for colorectal cancer. However, several loci
on chromosomes 2q, 3q, 6q, and 7q with suggestive linkage were detected in the parametric
analysis under the assumption of locus heterogeneity as well as in the nonparametric analysis.
Among these loci, the locus on chromosome 3q21.1-q26.2 was the most consistent finding
providing positive results in both parametric and nonparametric analyses Heterogeneity LOD
score (HLOD) = 1.90, alpha = 0.45, Non-Parametric LOD score (NPL) = 2.1).
Conclusion: The strongest evidence of linkage was seen for the region on chromosome 3.
Interestingly, the same region has recently been reported as the most significant finding in a
genome-wide analysis performed with SNP arrays; thus our results independently support the
finding on chromosome 3q.
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Background
Colorectal cancer is a major problem in the Western
world, ranking as the second most common cause of can-
cer-related death with a 5% lifetime risk. One of the
strongest associated risk factors for colorectal cancer is a
family history of the disease. From twin studies, Lichten-
stein has estimated that heritable factors account for 35%
of the risk [1]. Epidemiological studies suggested that the
risk of developing colorectal cancer for first-degree rela-
tives of patients diagnosed with colorectal cancer is
increased by two to four-fold [2]. Several hereditary syn-
dromes, such as FAP and HNPCC, are known where the
risk of colorectal cancer development can be as high as
100% and 80%, respectively [3]. FAP and HNPCC
account for less than 5% of all colorectal cancer cases [4-
6], and for the great majority of families with colorectal
cancer no hereditary cause of the disease has been identi-
fied. Most of these families do not fulfil the criteria for
FAP or HNPCC, but still provide empirical evidence of an
increased risk of developing colorectal cancer similar to
the one seen in HNPCC families [7-9]. These families are
characterized by a later age of onset of the disease com-
pared to HNPCC. A proportion of the remaining familial
clustering of colorectal cancer (CRC) might be due to the
involvement of low penetrance alleles [10]. Two papers
recently identified a locus on 8q24.21, suggested to har-
bour a low risk allele that predisposes to colorectal cancer
[11,12]. However, some families are expected to segregate
high to moderate penetrance genes inherited in a domi-
nant manner [13-15]. Several loci have been suggested to
predispose to hereditary colorectal cancer. A region on
chromosome 9q22.2-31.2 was suggested from a sib-pair
analysis and has been confirmed in two linkage studies
[16-18].
We have recently published a genome-wide study in 18
Swedish familial colorectal cancer families suggesting can-
didate loci on chromosomes 11 and 14 [19]. We now
extended this study and performed a genome-wide link-
age analysis in an additional set of 12 Swedish non-FAP/
non-HNPCC colorectal cancer families followed by a
combined analysis of data from both studies.
Methods
Description of families analysed
In total, 30 colorectal cancer families with 275 typed indi-
viduals were included in the study. All families were of
Swedish origin and were collected through the Family
Cancer Clinic at the Karolinska Hospital, Stockholm, Swe-
den. In all cases, the diagnosis was confirmed by medical
and pathological reports and informed consent was
obtained from all participants. The study was undertaken
in accordance with the Swedish legislation of ethical per-
mission (2003:460) and according to the decision in the
Stockholm regional ethical committee (Dnr: 2005/566-
31/1). FAP and MUTYH were excluded clinically since
only one of the individuals with CRC or under surveil-
lance had more than 4 polyps. This was a family with a
dominant inheritance pattern and the APC gene was
screened negative. Although none of the other families
(22 with a dominant pattern of inheritance) fulfilled the
criteria for screening, the APC gene had been screened in
20 of the families and the MUTYH gene in 15 of the fam-
ilies without any clearly pathogenic mutations found
[20,21]. This protocol includes microsatellite instability
(MSI) test, immunohistochemistry on selected tumours in
the family, and mutation screening of the DNA mismatch
repair genes hMLH1, hMSH2, hMSH6 or hPMS2 in cases
fulfilling Amsterdam criteria [22], cases with MSI positive
tumours, or with MSI negative tumours if any person had
colorectal cancer at an age before 50. Mutation screening
of mismatch repair genes was performed using direct
sequencing and Multiplex Ligation-dependent Probe
Amplification (MLPA). All members at increased risk were
counselled and offered regular colonoscopy. Eighteen out
of the 30 analysed families were included in our previous
screen where they were also described [19]. The 12 new
families are summarized in Table 1. In the whole data set,
there were 127 persons with positive colonoscopic find-
ings. Among these, 94 individuals had colorectal cancer
(70 colon cancer and 24 rectal cancer), 76 had adenomas
(range 1 to 13), and 27 individuals had hyperplastic pol-
yps only (range 1 to 16). Twenty-nine families had indi-
viduals affected in two or more generations, and one
family consisted of five affected siblings. Mean age of
onset in the 30 families varied from 46.7 to 73.3 years. For
association studies of allelic variants in the chromosome
3 locus we used another 190 unrelated familial colorectal
cancer cases and 190 healthy controls without a family
history of cancer from the same region matched for gen-
der and age.
Genotyping
Genomic DNA was extracted from peripheral blood by
standard procedures. Genotyping and a first-quality check
of the additional 12 families were done at deCODE
Table 1: The main characteristics of the 12 new families included in the linkage study
Family Number 87 119 125 237 256 301 322 340 350 397 409 478
Number of colorectal Cancer cases 3 56533347344
Number of affected 4 86533344545BMC Cancer 2008, 8:87 http://www.biomedcentral.com/1471-2407/8/87
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Genetics (Reykjavik, Iceland). A total of 545 fluorescently
labeled microsatellite markers located on the 22 auto-
somes and the X chromosome with an average marker
density of 7.25 cM were analyzed. Overall, 97.1% of the
genotypes were successfully determined. Genetic map was
used as provided by deCODE.
For fine mapping of the locus on chromosome 3 and 6 an
additional set of eleven and seven markers were typed,
respectively. Each marker was amplified separately
according to a standard PCR protocol (conditions are
available upon request). The PCR products were pooled
and separated on an ABI 377 DNA sequencer. Electro-
phoretic data were analyzed using the Genescan® and
Genotyper® software programs (Applied Biosystems, Fos-
ter city, CA, USA). In the combined analyses, the genetic
map was constructed using the Marshfield linkage maps
[23].
Linkage analysis
All genotyping data were reanalyzed concerning the Men-
delian inheritance and the relationship patterns of the
families using the Pedcheck program [24]. Any markers
violating Mendelian rules and with ambiguous genotypes
were deleted. No individuals were excluded since only
very few markers (in most cases none) were incorrect.
Marker allele frequencies were calculated from all the gen-
otyped individuals. Multipoint parametric analyses
including the calculation of heterogeneity LOD scores, as
well as nonparametric and haplotype analyses were com-
puted using the SimWalk2 program version 2.83 [25].
Individuals with positive colorectal findings were coded
as affected only if they had colorectal cancer or adenomas
with a high degree of dysplasia. Non-related family mem-
bers (spouses) were coded as unaffected and any other
family members as unknown. In addition, the data for
chromosome 3 and 9 obtained from combined analysis
from all thirty families were recoded using recently pub-
lished criteria for affected status and reanalysed using age-
dependant penetrance as described by Kemp et al. [18].
An autosomal dominant mode of inheritance with the
disease allele frequency of 0.0001 was used while the pen-
etrance and phenocopy rate were assumed as 80% and
5%, respectively. In addition, single point LOD score
analysis on chromosome X was performed using the
Fastlink program [26].
Direct sequencing
Database analysis revealed 340 genes (NCBI build 36)
within the 65 cM interval between markers D3S1558 and
D3S3592. Based on their known or hypothesized func-
tion we sequenced 20 genes in the region on chromosome
3 with a positive LOD score. Sequencing of 14 genes was
done as described in Sjöblom et al. [27]. For the other 6
genes we used a slightly modified protocol as described in
Liu et al. [28]. In short: primers were designed to amplify
all exons including exon/intron boundaries, the 5'- and
3'-UTR regions as well as the putative promoter for some
of them. Primers covering all exons were designed auto-
matically using the ExonPrimer function implemented in
the UCSC database [29] and the online Primer3 software
package to cover the putative promoter sequence [30]. The
coding sequence of the genes was analyzed using ABI
Seqscape v2.5 software, which allows alignment of multi-
ple samples for comparative sequence analysis with the
reference sequence in the databases.
Association studies
Genotyping of 10 SNPs on chromosome 3 was performed
using TaqMan SNP Genotyping Assay (Applied Biosys-
tems, Foster City, CA) in 190 familial colorectal cancer
cases and 190 healthy controls matched to patients
according to their gender and age. A standard PCR was
carried out in a 384-well format, with a total reaction vol-
ume of 5 μl using 6 ng genomic DNA diluted in 2.375 μl
H2O, 2.5 μl TaqMan Universal PCR Master Mix (Applied
Biosystems, Foster City, CA) and 0.125 μl Assay. The SNP
genotyping assay contains two primers for amplifying the
sequence and two probes for detecting alleles. Each probe
contains a reporter dye at the 5'-end; specifically, the VIC
dye is linked to the allele 1 probe and the FAM dye is
linked to the allele 2 probe. After the initial denaturation
step at 95°C for 10 min there were 40 cycles of denatura-
tion at 92°C for 15 sec, annealing and extending at 60°C
for 1 min. The fluorescence was measured after the last
PCR cycle was completed by the ABI PRISM 7900 HT
instrument (Applied Biosystems, Foster City, CA) in
which the fluorescence intensity of each well was read.
Negative and positive controls were included in all analy-
ses as a quality control measure. Fluorescence data files
from each plate were analyzed using the SDS 2.2.1 soft-
ware (Applied Biosystems, Foster City, CA). We used Hap-
loview [31] to determine whether individual variants were
in equilibrium at each locus in the population (Hardy-
Weinberg equilibrium) and to check for the presence of
association between single SNPs or block of several SNPs
(haplotypes) and CRC.
Results
Genome-wide linkage analysis in the combined data set
In the combined data set of the 30 families, genome-wide
linkage analysis did not reveal any locus with a statisti-
cally significant LOD score. However, genome-wide
HLOD scores over 1 and NPL scores over 1.3 (p-value <
0.05) providing evidence for suggestive linkage were
obtained in both parametric and nonparametric linkage
analyses. Overall, four regions with p-value < 0.05 were
identified. The results are summarized in table 2. In theBMC Cancer 2008, 8:87 http://www.biomedcentral.com/1471-2407/8/87
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multipoint parametric analysis the highest genome-wide
HLOD score providing evidence for suggestive linkage
was obtained for the marker D3S1279 located at 168.28
cM (HLOD = 1.90, α = 0.45). The highest NPL score of 2.1
(p-value = 0.008) was obtained for the same marker.
Three other loci, on chromosomes 2q, 6q and 7q, pro-
vided parametric HLOD higher than or equal to 1. The
second most significant HLOD was reached for the region
on chromosome 7q (HLOD = 1.70, α = 0.70), while con-
sidering the NPL was on chromosome 6 (NPL = 1.50, p-
value = 0.03).
Fine mapping and sequencing on chromosome 3q
Eight families with possible linkage to chromosome 3q
were included in subsequent fine mapping. Positive LOD
scores were detected for the region between D3S1558 and
D3S3592 spanning 65 cM (Figure 1). However, no single
overlapping region shared by all families was identified in
the haplotype analysis. Instead, two linkage peaks were
observed; one around marker D3S1593 and a second one
around marker D3S1584 where six (Fam. 70, Fam. 119,
Fam. 125, Fam. 197, Fam. 242, Fam. 256) and five fami-
lies (Fam. 119, Fam. 125, Fam. 242, Fam. 256, Fam. 309)
contributed with positive LOD scores, respectively.
In order to further investigate the linked region we
sequenced 20 candidate genes (PIK3R4, ASTE1, NEK11,
NUDT16, MRPL3, TOPBP1, SRPRB, RAB6B, RYK,
PPP2R3A, PIK3CB, RNF7, TFDP2, SLC9A9, MGC33365,
PLOD2, PLSCR1, PLSCR2, PLSCR4, PLSCR5), on the
basis of their known or predicted function and position
near the markers that showed the highest LOD score. We
sequenced the exons, the intron/exon boundaries, 5' and
3' UTR and, for some genes, the promoter region. No del-
eterious mutations were found, but instead many variants
(missense, silent, intronic and in the promoter), already
reported in the databases, were recorded. We were partic-
ularly interested in family 242 because it gives the largest
contribution to the LOD score values on chromosome 3.
Ten SNPs (rs9864242, rs3738000, rs9843898,
rs3762802, rs3762803, rs2291382, rs17301766,
rs3192149, rs9814557, rs17197552) were present on the
disease haplotype in family 242. Association studies were
performed to test these 10 SNPs using 190 familial color-
ectal cancer cases and 190 controls without a family his-
tory. Eight SNPs had a frequency above 5%, were tested
and did not show significant differences between the two
groups; 2 SNPs (rs2291382 and rs3762802) had a fre-
quency below 5%, 8 cases and 7 controls were found in
the two groups respectively and no further tests were per-
formed.
Genome-wide linkage analysis in the 12 new families
In the 12 new families, 545 microsatellite markers were
used for genotyping, compared to 400 markers in our first
screening with 18 families. For this reason we analyzed
the 12 new families separately as well. The strongest evi-
dence of linkage was found on chromosome 6q22.3-24.3
with an NPL score of 2.06 (p-value = 0.01) for D6S1656.
Furthermore, a p-value < 0.05 was obtained for three addi-
tional loci on chromosomes 1p36.22, 3q24-25.1, and
13q33.2. Under the assumption of locus heterogeneity,
linkage was most evident in the region on chromosome
6q22-23. The highest HLOD score was obtained for
marker D6S270 (HLOD = 1.68 for α = 0.4). Positive
HLOD scores of 1.59 (α = 0.4) and 1.39 (α = 0.45) were
seen in this analysis for both flanking markers, D6S1656
and D6S1009, respectively and supported the results
obtained for this region in the nonparametric analysis.
Out of the 12 families, seven provided positive LOD
scores for this region. Fine mapping on chromosome 6q
using additional 11 markers confirmed the results and
determined the region of linkage between markers
D6S1712 and D6S1637 (30 cM) with a NPL peak of 2.3
for 2 closely located markers (250 kbp), D6S976 and
D6S270. No common shared haplotype was found
among the linked families.
Discussion
We have recently presented results from a genome-wide
screen in 18 Swedish colorectal cancer families. In order to
further evaluate and narrow down regions of suggestive
linkage, we extended our family material with 12 addi-
tional families, and combined the results from the new
genome-wide analysis in the 12 families with our previ-
ously published findings.
In our combined analysis containing 275 subjects from 30
non-FAP/non-HNPCC colorectal cancer families, we did
not find any support for the two loci on chromosomes 11
and 14 suggested from the previous analysis of 18 of the
families. Instead, we now found suggestive linkage to
chromosome 3q, and the same region was also suggested
from the nonparametric analysis of 12 families alone.
Interestingly, our candidate region of approximately 65
cM between markers D3S1558 and D3S3592 on chromo-
some 3q13.31-q27.1 overlaps that recently identified as
the most significant finding by Kemp et al. [32]. Their
Table 2: 
Location Marker HLOD α-value NPL Score p-value
2q37.3 D2S140 1.09 0.70 1.00 0.100
3q25.1 D3S1279 1.90 0.45 2.10 0.008
6q23.2 D6S270 1.30 0.40 1.50 0.030
7q11.21 D7S2429 1.70 0.70 1.20 0.050
Summary of all linkage peaks with HLOD scores greater than 1 and 
their corresponding NPL scores obtained in linkage analysis in 30 
colorectal cancer families with 275 typed individualsBMC Cancer 2008, 8:87 http://www.biomedcentral.com/1471-2407/8/87
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Linkage analysis and haplotype analysis on chromosome 3 after fine mapping in the 8 linked families Figure 1
Linkage analysis and haplotype analysis on chromosome 3 after fine mapping in the 8 linked families. The 
genomic regions included in the bolded boxes indicate a positive LOD scores for those markers. The marker map is based on 
the Marshfield map.
  cM   70     119    125    197    242    256    309    409 LOD  score
D3S3547  55.11                              -8,7 
D3S1277  61.52                               -8,3 
D3S3521  63.12                               -6,6 
D3S1289  71.41                               -5,4 
D3S3672  72.21                               -5,4 
D3S1300  80.32                               -5,5 
D3S1600  85.97                                -6,1 
D3S1285  91.18                                -5 
D3S1566  97.75                                -4,7 
D3S3551  99.38                                -4,2 
D3S3653  107.19                                -3,2 
D3S3681  109.22                                -3,2 
D3S1271  117.76                                -4,3 
D3S3045  124.16                                -2,9 
D3S1278  129.73                                  -1,3 
D3S1558  133.93                                  0,4 
D3S1267  139.12                                  0,9 
D3S1292  146.60                                   2,1 
D3S3637  149.80                                   0,5 
D3S1309  153.74                                     1,2 
D3S1569  158.38                                     3,6 
D3S1593  161.04                                     4,1 
D3S3618  163.18                                     3,2 
D3S3626  164.25                                    1,8 
D3S1308  165.85                                   0,3 
D3S1299  166.93                                   0,8 
D3S1279  169.60                                    3,2 
D3S1584  170.14                                    3,8 
D3S1275  172.27                                    1,7 
D3S1607  172.27                                    1,9 
D3S1614  177.75                                   1,6 
D3S1564  180.80                                   2,5 
D3S3725  181.87                                   2,8 
D3S1565  186.04                                  1,8 
D3S3041  188.29                                  1,6 
D3S3592  198.68                                  0,2 
D3S1262  201.14                                 -1 
D3S1580  207.73                                 -1,6 
D3S1601  214.45                               -4,3 
D3S3663  214.45                               -4,4 
D3S240    218.66                               -2,9 
D3S1265  222.83                               -2,4 
D3S1311  224.88                               -2,2 
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region was 17.8 Mbp in length and includes over 90 Ref-
Seq genes. They screened two genes, representing candi-
dates on the basis of their biology, without finding any
potential pathogenic change [32]. Our region is wider and
contains 340 genes; we studied 20 of them based on their
known or presumptive function, or location in vicinity of
the highest LOD score values, without finding any clearly
pathogenic mutations.
In the analysis using the 12 new families alone, the strong-
est linkage (NPL = 2.3) was observed for the markers
D6S976 and D6S270, and the candidate region was iden-
tified between D6S1712 and D6S1637 (30 cM). This
locus was further supported in the pooled analysis using
all 30 families where suggestive NPL scores for these
markers were provided in nonparametric analysis. The
same locus has previously been suggested from the link-
age analysis using sib pairs affected with colorectal adeno-
mas and carcinomas [17]. In that study, a smaller region
on chromosome 6q23.1-23.3 located between markers
D6S1040 and D6S1009 provided a significant result (p =
0.01) in a group of concordantly affected sib pairs. The
region, however, failed to reach statistical significance
among discordantly affected siblings and concordantly
unaffected siblings [17].
No confirmation of the previously published region on
chromosome 9q22.2-q31 was found. Neither was any
support of linkage found when the analysis was per-
formed using a criteria for affected status and age depend-
ant penetrance as described by Kemp et al [18]. In the two
previously published studies identifying linkage to chro-
mosome 9q, the affected individuals had age of onset
below 65 and 55 years, respectively. We also performed
analysis based on age subgroups, but no linkage to chro-
mosome 9 was detected in either subgroup.
Conclusion
Our data support the idea of a genetic heterogeneity
among colorectal cancer families, and indicate that a fur-
ther subdivision of families into groups sharing similar
phenotypic and molecular features is needed. Several loci
with suggestive linkage were detected in the parametric
analysis performed under the assumption of locus hetero-
geneity as well as in the nonparametric analysis. The
strongest evidence of linkage was seen to the region on
chromosome 3. Interestingly, the same region has recently
been reported as the most significant finding in the
genome-wide analysis performed with SNP arrays by
Kemp et al[32]; thus, our results represent an independent
confirmation, but further studies are needed in order to
determine the significance of this region as well as the
other regions suggested from this study.
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